26th July 2022
We are delighted to announce Phase 2 of Point of care diagnostics (if you are interested in Phase 1, the information is here).
In Phase 2, we have £1m and expect to fund 1-2 projects which will finish at TRL5. We are looking for innovations that enable front-line clinicians to diagnose and treat individuals exposed to biological or chemical agents in approximately 1 hour. The technology should also be able to be used in proximity to the patient and in demanding austere locations. We have the following requirements:
- Minimal or no requirement for manual sample preparation (blood, serum, plasma, saliva etc).
- Provide a rapid (c. 1 hour or less) time to answer, to facilitate delivery of timely information to clinicians to inform treatment options.
- Provide high confidence information outputs.
- Flexible and adaptable to the integration of new assays for additional analytes to facilitate the identification of a broad spectrum of agents.
We are running a webinar on 03 August, signup is here
The full competition document is here
If you have any questions, please get in touch.